HBK Sorce Advisory LLC Takes $540,000 Position in HCA Healthcare, Inc. $HCA

HBK Sorce Advisory LLC acquired a new position in HCA Healthcare, Inc. (NYSE:HCA) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 1,267 shares of the company’s stock, valued at approximately $540,000.

Several other hedge funds have also added to or reduced their stakes in the stock. Norges Bank bought a new position in shares of HCA Healthcare during the 2nd quarter valued at approximately $1,152,408,000. Pacer Advisors Inc. increased its position in HCA Healthcare by 6,115.3% in the third quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock worth $388,309,000 after buying an additional 896,437 shares during the last quarter. Viking Global Investors LP grew its stake in shares of HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after acquiring an additional 690,773 shares during the period. Abdiel Capital Advisors LP bought a new stake in HCA Healthcare in the 1st quarter valued at about $164,835,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of HCA Healthcare in the second quarter worth about $109,337,000. Institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This trade represents a 52.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is owned by insiders.

HCA Healthcare Price Performance

Shares of HCA opened at $473.13 on Wednesday. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $520.00. The company has a market capitalization of $107.96 billion, a P/E ratio of 18.29, a P/E/G ratio of 1.40 and a beta of 1.36. The firm’s 50 day simple moving average is $477.30 and its 200 day simple moving average is $422.24.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the company posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, December 29th. Investors of record on Monday, December 15th were issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend was Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.13%.

Analysts Set New Price Targets

Several research analysts recently commented on HCA shares. KeyCorp raised their price objective on shares of HCA Healthcare from $465.00 to $475.00 and gave the stock an “overweight” rating in a report on Monday, October 27th. Wells Fargo & Company boosted their price objective on HCA Healthcare from $412.00 to $431.00 and gave the company an “equal weight” rating in a research note on Thursday, November 13th. Stephens lifted their target price on HCA Healthcare from $450.00 to $500.00 and gave the company an “overweight” rating in a report on Monday, October 27th. Wall Street Zen upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 25th. Finally, Raymond James Financial set a $525.00 target price on shares of HCA Healthcare in a research note on Monday, October 27th. Fourteen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $479.00.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.